| Literature DB >> 36003177 |
Ahmed H Aly1,2, Yoshiaki Saito1,3, Wobbe Bouma4, James J Pilla1,5, Alison M Pouch1,5, Paul A Yushkevich5, Matthew J Gillespie1,6, Joseph H Gorman1,7, Robert C Gorman1,7.
Abstract
Background: The exact geometric pathogenesis of leaflet tethering in ischemic mitral regurgitation (IMR) and the relative contribution of each component of the mitral valve complex (MVC) remain largely unknown. In this study, we sought to further elucidate mitral valve (MV) leaflet remodeling and papillary muscle dynamics in an ovine model of IMR with magnetic resonance imaging (MRI) and 3-dimensional echocardiography (3DE).Entities:
Keywords: 2D, two-dimensional; 3D echocardiography; 3DE, 3-dimensional echocardiography; AC, anterior commissure; ALPM, anterolateral papillary muscle; ANC, annular center; BNM, bilateral noncongruent movement; IMR, ischemic mitral regurgitation; LV, left ventricular; MI, myocardial infarction; MV, mitral valve; MVC, mitral valve complex; PM, papillary muscle; PMPM, posteromedial papillary muscle; image analysis; ischemic mitral regurgitation; magnetic resonance imaging; multimodal imaging
Year: 2020 PMID: 36003177 PMCID: PMC9390375 DOI: 10.1016/j.xjon.2020.10.007
Source DB: PubMed Journal: JTCVS Open ISSN: 2666-2736
Figure 1Overview of the study. Using magnetic resonance imaging and 3-dimensional echocardiography, we followed 6 ischemic mitral regurgitation (IMR) ovine models at baseline, 30 minutes post–myocardial infarction (MI), and 12 weeks post-MI to study the valvular and subvalvular apparatus of the mitral valve in IMR. This could allow for better preoperative planning and tailoring of adjunct surgical treatment.
Figure 2Magnetic resonance imaging (MRI) image processing technique. Two-dimensional multislice images were reconstructed with volume segmentation and processing software. A, Reconstructed 3-dimensional (3D) model of baseline MRI. The anterolateral papillary muscle (ALPM) is marked with yellow, and the posteromedial papillary muscle (PMPM) is in light blue. B, Late gadolinium-enhanced MRI at 12 weeks after myocardial infarction (MI). Short-axis view. C and D, 3D reconstructed model at 12 weeks post-MI in the same animal as in A. The infarcted area (INF) is marked in brown. C, Atrial view. D, Posteromedial view.
MRI volumetric data
| Variable | Baseline | 12 wk post-MI |
|---|---|---|
| LV muscle volume (infarcted muscle volume), cm3 | 99.5 ± 12.3 | 102.6 ± 16.3 (10.0 ± 4.2) |
| Anterolateral papillary muscle volume, cm3 | 2.7 ± 1.1 | 3.3 ± 1.2 |
| Posteromedial papillary muscle volume, cm3 | 1.9 ± 0.2 | 0.9 ± 0.3 |
| Anterior ventricular wall thickness, mm | 8.1 ± 0.3 | 8.8 ± 0.9 |
| Posterior ventricular wall thickness, mm | 9.0 ± 0.6 | 4.8 ± 0.5 |
| Septal ventricular wall thickness, mm | 9.5 ± 0.5 | 10.1 ± 0.9 |
| LVEF, % | 61.1 ± 5.9 | 42.8 ± 5.5 |
| LVEDV, mL | 86.4 ± 13.0 | 128.7 ± 23.0 |
| LVESV, mL | 33.8 ± 8.2 | 74.2 ± 19.5 |
All values are mean ± SD. MI, Myocardial infarction; LV, left ventricular; LVEF, left ventricular ejection fraction; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume.
P < .05 vs baseline.
Figure 3Regional mitral valve (MV) leaflet adaptation. A, Regional anterior MV leaflet length at baseline (blue), 30 minutes post–myocardial infarction (MI) (red), and 12 weeks post-MI (green). The leaflet length is plotted as a function of intercommissural distance, expressed as a percentage of the distance traveled from the anterior commissure (AC). The positions of the AC and posterior commissure (PC) are 0% and 100%, respectively. B, Regional posterior valve leaflet length at baseline (blue), 30 minutes post-MI (red), and 12 weeks post-MI (green).
Mitral valve regional leaflet remodeling
| Variable | Baseline | 30 min post-MI | 12 wk post-MI | Fixed-effect correlation |
|---|---|---|---|---|
| Leaflet length, mm | ||||
| A1 | 8.1 ± 2.0 | 8.4 ± 1.5 | 10.3 ± 1.1 | 0.690 |
| A2 (left half) | 13.6 ± 1.4 | 13.7 ± 1.8 | 17.4 ± 0.5 | 0.879 |
| A2 (right half) | 15.2 ± 1.4 | 15.3 ± 1.4 | 19.2 ± 0.8 | 0.877 |
| A3 | 10.6 ± 1.9 | 10.8 ± 0.6 | 16.5 ± 2.3 | 0.926 |
| P1 | 11.0 ± 2.6 | 10.0 ± 1.6 | 10.8 ± 2.2 | 0.592 |
| P2 (left half) | 13.1 ± 3.0 | 12.7 ± 2.6 | 11.0 ± 2.9 | 0.549 |
| P2 (right half) | 12.0 ± 3.0 | 11.6 ± 1.9 | 10.1 ± 2.8 | 0.570 |
| P3 | 9.8 ± 3.1 | 9.8 ± 2.9 | 5.9 ± 1.3 | 0.831 |
All values are mean ± SD. MI, Myocardial infarction.
P < .05 vs baseline.
P < .05 vs 30 min post-MI.
End-diastolic and end-systolic interpapillary muscle distance and papillary muscle to annular distance
| Parameter | Baseline | 30 min post-MI | 12 wk post-MI | |||
|---|---|---|---|---|---|---|
| ED | ES | ED | ES | ED | ES | |
| ALPM to, mm | ||||||
| mid-AA | 26.9 ± 3.0 | 26.6 ± 2.9 | 28.1 ± 1.8 | 28.8 ± 2.3 | 28.9 ± 2.1 | 30.1 ± 3.5 |
| AC | 19.4 ± 3.4 | 19.7 ± 2.2 | 19.6 ± 2.9 | 20.8 ± 2.5 | 22.0 ± 4.1 | 20.4 ± 4.0 |
| PC | 36.1 ± 2.5 | 30.3 ± 2.6 | 36.9 ± 1.1 | 33.0 ± 2.2 | 38.4 ± 2.5 | 34.4 ± 3.9 |
| mid-PA | 29.0 ± 3.3 | 28.1 ± 2.2 | 29.5 ± 2.7 | 27.9 ± 2.5 | 28.4 ± 3.6 | 27.3 ± 5.3 |
| ANC | 24.2 ± 2.2 | 22.4 ± 1.7 | 24.9 ± 1.8 | 23.7 ± 2.0 | 23.8 ± 1.8 | 24.1 ± 3.2 |
| PMPM to, mm | ||||||
| mid-AA | 29.3 ± 3.2 | 28.8 ± 2.7 | 29.2 ± 0.8 | 30.7 ± 1.4 | 37.0 ± 3.1 | 38.1 ± 4.1 |
| AC | 34.4 ± 5.3 | 30.4 ± 5.3 | 35.5 ± 2.4 | 31.3 ± 2.7 | 46.0 ± 3.8 | 42.3 ± 4.1 |
| PC | 20.3 ± 2.8 | 19.4 ± 2.5 | 21.0 ± 2.6 | 21.5 ± 1.3 | 25.7 ± 2.3 | 24.6 ± 1.6 |
| mid-PA | 23.5 ± 4.0 | 23.0 ± 2.5 | 23.4 ± 1.6 | 21.2 ± 2.6 | 30.0 ± 4.7 | 28.5 ± 3.9 |
| ANC | 22.7 ± 3.3 | 21.0 ± 2.9 | 22.4 ± 1.7 | 21.2 ± 1.3 | 30.3 ± 3.4 | 29.8 ± 3.5 |
| ALPM - PMPM distance, mm | 30.1 ± 1.9 | 20.6 ± 2.9 | 29.8 ± 2.6 | 22.7 ± 3.8 | 37.2 ± 5.9 | 33.3 ± 5.0 |
All values are mean ± SD. MI, Myocardial infarction; ED, end-diastolic phase; ES, end-systolic phase; ALPM, anterolateral papillary muscle; AA, anterior mitral annulus; AC, anterior commissure; PC, posterior commissure; PA, posterior mitral annulus; ANC, mitral annular center; PMPM, posteromedial papillary muscle.
P < .05 vs baseline end-systolic phase.
P < .05 vs baseline end-diastolic phase.
P < .05 vs 30 min post-MI end-diastolic phase.
P < .05 vs 30 min post-MI end-systolic phase.
Figure 4Coordinate system used to calculate position and dynamics of the papillary muscles. The mitral annular center (ANC) was set as the coordinate origin. We defined the positive X direction as the vector pointing toward the posterior horn of the mitral annulus. We defined the positive Y direction as the vector pointing toward the posterior commissure and the positive Z direction as the vector pointing toward the left atrial roof. PCM, Posterior commissure; AAOP, anterior aortic peak; MPA, midpoint of posterior annulus; AC, anterior commissure; LV, left ventricular.
Figure 5Papillary muscle (PM) tracing technique. A, Resected heart after euthanization. The right ventricle and atria were removed, and the left ventricular septum was cut longitudinally from the aortic root toward the apex. The number of PM tips and anatomic characteristics were identified. B, Oblique view of 2-dimensional echocardiography (2DE) at baseline. PM tips were marked according to the anatomic characteristics obtained from the resected specimen. C, Short-axis view of 2-DE with the PMs marked. D and E, Traced annulus and leaflets along with marked PMs in right lateral oblique view (D) and front view from the left atrial side (E). ALPM, Anterolateral papillary muscle; PMPM, posteromedial papillary muscle.
Figure 6A new papillary dynamics framework in ischemic mitral regurgitation (IMR) pathogenesis. At baseline, papillary muscle (PM) movement can be described as bilateral congruent movement with full range of motion and preserved PM to the annular center distance (PM-ANC). In the acute phase of IMR, the PPM motion is dampened with preserved PM-ANC and can thus be described as bilateral noncongruent movement. In chronic IMR, the PM movement is unilateral with minimal PPM movement (SUM1) or strictly no PPM movement (SUM2). SUM, Strict unilateral movement.
3DE-derived measurements and landmarks
| Landmarks and measurements | Definition |
|---|---|
| Anterior and posterior commissures | Annular points at the junction between the anterior and posterior leaflets |
| Annular height, mm | Distance between the midpoint of the anterior annulus and the best-fitted plane to annulus |
| Intercommissural width, mm | Distance between the commissures |
| Septolateral diameter, mm | Distance between the anterior and posterior annular midpoints |
| Annular height to commissural width ratio | Metric of global annular nonplanarity |
| Annular area, mm2 | Area of the annular projection onto the least-squares plane |
| Tenting area, mm2 | Area enclosed between the mitral leaflets and the annular plane |
| Tenting index, mm | Tenting volume divided by the mitral annular area |
| Anterior and posterior tenting angles, ° | Angle formed by the line tangent to the anterior or posterior leaflet and the mitral annular plane computed |
| Mean segmental tethering angles, ° | Mean tethering angles for the 6 leaflet regions A1, A2, A3, P1, P2, and P3 |
| Coaptation area, mm2 | Sum of the incremental coaptation length along the intercommissural axis |
| Total leaflet area, mm2 | Sum of the incremental leaflet lengths |
| Anterolateral papillary muscle tip | Landmark at chordae endpoints attached in the region between A1, A2 and P1, P2 |
| Posteromedial papillary muscle tip | Landmark at chordae endpoints attached in the regions A2, A3 and P2, P3 |
The papillary muscle tips were traced retrospectively using resected heart specimens as ground truth for tracing the papillary muscle tips with the TOMTEC. If several papillary muscle tips were identified in 3D images, the coordinates were averaged.
Hemodynamic parameters and degree of mitral regurgitation
| Hemodynamic parameter | Baseline | 30 min post-MI | 12 wk post-MI |
|---|---|---|---|
| Heart rate, bpm | 89.5 ± 14.0 | 88.5 ± 5.1 | 96.7 ± 15.0 |
| Systolic ABP, mm Hg | 105.7 ± 14.9 | 96.3 ± 8.6 | 103.0 ± 13.5 |
| Systolic PAP, mm Hg | 25.7 ± 5.2 | 33.0 ± 7.1 | 35.3 ± 3.8 |
| PCWP, mm Hg | 12.0 ± 1.8 | 17.3 ± 5.0 | 19.7 ± 1.9 |
| CVP, mm Hg | 6.6 ± 1.8 | 9.0 ± 4.5 | 8.3 ± 3.1 |
| Degree of MR | 0.7 ± 0.5 | 1.0 ± 0.6 | 3.2 ± 0.4 |
All values are shown in mean ± SD. MI, Myocardial infarction; ABP, arterial blood pressure; PAP, pulmonary arterial pressure; PCWP, pulmonary capillary wedge pressure; CVP, central venous pressure; MR, mitral regurgitation.
P < .05 vs baseline.
P < .05 vs 30 min post-MI.
Mitral valve geometric data in the systolic phase
| Variable | Baseline | 30-min post-MI | 12 wk post-MI | Fixed-effect correlation |
|---|---|---|---|---|
| Mitral annular area, mm2 | 682 ± 133 | 703 ± 105 | 822 ± 192 | 0.641 |
| Septolateral diameter, mm | 25.9 ± 2.5 | 27.0 ± 2.1 | 28.8 ± 3.1 | 0.594 |
| Commissural width, mm2 | 33.2 ± 3.8 | 32.8 ± 2.7 | 36.3 ± 4.2 | 0.665 |
| Transverse diameter, mm | 32.7 ± 3.4 | 33.1 ± 2.9 | 36.5 ± 3.8 | 0.682 |
| Annular circumference, mm | 101 ± 10 | 102 ± 8 | 113 ± 12 | 0.697 |
| Annular height, mm | 4.0 ± 1.5 | 3.7 ± 0.9 | 3.8 ± 0.9 | |
| Annular height:commissural width ratio, % | 11.8 ± 3.9 | 10.7 ± 2.5 | 10.2 ± 3.0 | |
| Mitral valve leaflet area, mm2 | 730 ± 84 | 715 ± 90 | 849 ± 67 | 0.732 |
| Anterior leaflet | 363 ± 85 | 366 ± 52 | 526 ± 67 | 0.837 |
| Posterior leaflet | 367 ± 119 | 349 ± 80 | 324 ± 98 | 0.623 |
| Mitral valve tenting volume, mm3 | 456 ± 206 | 657 ± 448 | 0.888 | |
| Mitral valve tenting index | 0.71 ± 0.45 | 0.94 ± 0.63 | 1.77 ± 0.52 | 0.816 |
| Segmental tethering angle, ° | ||||
| A1 | 6.1 ± 3.4 | 8.4 ± 3.4 | 11.4 ± 3.2 | 0.823 |
| A2 | 8.7 ± 5.8 | 10.4 ± 6.4 | 14.5 ± 4.6 | 0.711 |
| A3 | 3.2 ± 2.2 | 3.7 ± 2.8 | 5.9 ± 1.9 | 0.740 |
| P1 | 4.9 ± 3.2 | 7.1 ± 3.2 | 10.3 ± 1.6 | 0.846 |
| P2 | 10.4 ± 7.5 | 12.3 ± 6.6 | 27.3 ± 8.7 | 0.742 |
| P3 | 3.3 ± 2.4 | 3.8 ± 2.4 | 20.0 ± 9.0 | 0.916 |
All values are mean ± SD. MI, Myocardial infarction.
P < .05 vs baseline.
P < .05 vs 30 minutes post-MI.
LV parameters from resected specimens 12 weeks after MI
| Parameter | 12 wk post-MI |
|---|---|
| LV weight, g | 214.4 ± 29.0 |
| LV area, cm2 | 112.0 ± 17.6 |
| LV infarction area, cm2 | 25.2 ± 5.3 |
| LV infarction ratio, % | 22.4 ± 1.4 |
| Number of ALPM heads | 2.8 ± 0.8 |
| Number of PMPM heads | 2.2 ± 0.4 |
Values are mean ± SD. MI, Myocardial infarction; LV, left ventricular; ALPM, anterolateral papillary muscle; PMPM, posteromedial papillary muscle.
Geometric papillary muscle position in Cartesian coordinates throughout cardiac cycle
| Coordinates | Baseline | 30 min post-MI | 12 wk post-MI | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ED | ES | ES-ED | ED | ES | ES-ED | ED | ES | ES-ED | |
| ALPM position, mm | |||||||||
| | −2.1 ± 2.7 | −1.7 ± 2.6 | 0.3 ± 2.3 | −0.7 ± 2.7 | −1.0 ± 2.0 | −0.3 ± 1.9 | 2.4 ± 2.4 | 1.2 ± 3.3 | 1.2 ± 1.9 |
| | −16.7 ± 2.7 | −11.5 ± 3.9 | 5.2 ± 1.5 | −17.4 ± 2.4 | −11.8 ± 3.2 | 5.6 ± 1.2 | −15.4 ± 3.4 | −10.6 ± 4.5 | 4.8 ± 2.7 |
| | −17.0 ± 2.9 | −18.6 ± 2.0 | −1.6 ± 2.7 | −17.5 ± 2.1 | −20.3 ± 1.9 | −2.8 ± 1.3 | −17.5 ± 3.0 | −21.0 ± 3.8 | −3.5 ± 3.3 |
| PMPM position, mm | |||||||||
| | 5.6 ± 1.8 | 3.8 ± 2.4 | 1.8 ± 1.4 | 6.2 ± 1.2 | 6.0 ± 2.6 | 0.2 ± 2.0 | 9.3 ± 5.0 | 9.5 ± 3.9 | −0.2 ± 1.7 |
| | 12.0 ± 4.2 | 8.0 ± 4.2 | 3.9 ± 2.1 | 11.4 ± 3.8 | 9.3 ± 3.4 | 2.1 ± 1.9 | 20.7 ± 4.6 | 20.8 ± 3.9 | −0.1 ± 2.6 |
| | −18.1 ± 2.7 | −18.6 ± 2.2 | −0.5 ± 1.8 | −17.8 ± 2.7 | −17.6 ± 1.8 | 0.2 ± 2.7 | −19.2 ± 3.1 | −18.6 ± 2.8 | 0.6 ± 1.1 |
All values are mean ± SD. MI, Myocardial infarction; ED, end-diastolic phase; ES, end-systolic phase; ED-ES, distance between end-diastolic and end-systolic phases; ALPM, anterolateral papillary muscle; PMPM, posteromedial papillary muscle.